Nov 11 2010
A pioneering new assay-ready, on-demand chemical supply service has been announced today as the result of a partnership between Molplex and Peakdale Molecular.
The new service will radically cut the cost of accessing chemical libraries for drug discovery by providing sophisticated chemical selection systems, allowing customers to choose only those chemicals most likely to be useful and only in the quantity and format they need for a testing.
Eliminating the high start-up costs of chemistry in early drug discovery, the service aims to empower the emerging ecosystem of "Micro Pharmas" by helping them to succeed at inventing new medicines at lower cost.
Molplex CEO David Leahy said: "Peakdale and Molplex share the same vision of delivering high quality chemical services on demand that enable innovative drug discovery teams to invent new medicines. We're committed to offering high quality chemical supply services at low cost by using novel technology and allowing customers to order economically and affordably."
Peakdale CEO, Ray Fisher said "We have over 25 years experience in providing high quality and knowledgeable chemical synthesis and supply support to the world's largest pharmaceutical companies. Molplex's highly innovative on demand drug discovery service puts our high quality chemistry and deep chemical experience at the service of drug discovery teams based anywhere in the world."